NuVasive will participate in the 21st International Meeting on Advanced Spine Techniques on July 16 to 21 in Spain.
Spinal Tech
Device company Paradigm Spine has published two separate independent prospective clinical studies that examine the short- and long-term durability of coflex interlaminar stabilization. Here are four things to know about the two studies.
Stryker's Director Ronda E. Stryker sold 14,000 shares of the company on July 3, according to a WKRB News & Analysis report.
Medtronic plans to cut 40 jobs in Minnesota, according to a Minneapolis/St. Paul Business Journal report.
Stryker has sold its bone morphogenetic protein-7 assets to Mariel Therapeutics. The companies entered into a definitive agreement announced yesterday.
Benvenue Medical named 20-year industry veteran Jeffrey Jones chief operating officer.
Munich Innovation, based in Germany, plans to acquire the Magnetodyn patented portfolio of bone and tissue regeneration technology.
NuVasive named Carol Cox executive vice president of strategy and corporate communications, reporting directly to chairman and CEO Alex Lukianov.
MicroPort Orthopedics and MB Innovations entered into a multi-product development agreement for orthopedic instruments, according to a Pharmiweb report.
Exactech Executive Vice President Gary J. Miller sold 12,392 more shares of the company's stock last Tuesday, according to a Mideast Times report.
